Canada markets closed

CARISMA Therapeutics Inc (W2J.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
1.2520+0.0180 (+1.46%)
At close: 09:59PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-81,215
-86,879
-61,226
-40,784
-28,349
Depreciation & amortization
3,825
2,837
1,893
682
448
Stock based compensation
3,108
2,316
275
479
163
Change in working capital
-8,860
-5,436
45,196
1,461
-453
Accounts Payable
-2,458
2,191
-473
-974
1,282
Other working capital
-79,082
-82,309
-9,776
-39,199
-27,452
Other non-cash items
5,793
6,850
6,827
834
1,179
Net cash provided by operating activites
-78,068
-81,177
-5,116
-37,328
-27,012
Cash flows from investing activities
Investments in property, plant and equipment
-1,014
-1,132
-4,660
-1,871
-440
Purchases of investments
0
-34,460
-90,900
-
-
Sales/Maturities of investments
77,000
108,000
63,000
-
-
Net cash used for investing activites
75,986
72,408
-32,560
-1,871
-440
Cash flows from financing activities
Debt repayment
-2,514
-1,301
-865
-
-
Common stock issued
2,883
31,237
0
-
-
Other financing activites
-4,768
32,057
-922
-366
-
Net cash used privided by (used for) financing activities
-4,210
62,180
33,319
15,962
72,258
Net change in cash
-6,292
53,411
-4,357
-23,237
44,806
Cash at beginning of period
62,807
24,194
28,551
51,788
6,982
Cash at end of period
56,515
77,605
24,194
28,551
51,788
Free Cash Flow
Operating Cash Flow
-78,068
-81,177
-5,116
-37,328
-27,012
Capital Expenditure
-1,014
-1,132
-4,660
-1,871
-440
Free Cash Flow
-79,082
-82,309
-9,776
-39,199
-27,452